Latest filing published 11 Jun 2026 for Fennec Pharmaceuticals INC., €108k.
Filing timeline
BuySaleInsider track record
Chris Anigeron Rallis: trading record in brief
Chris Anigeron Rallis appears in our data through filings on Fennec Pharmaceuticals Inc. shares, published by SEC (Form 4). Over a trading history stretching from 25 August 2011 to 10 June 2026, the count stands at 36 filings.
Both buying and selling appear: 14 purchases worth €401k, against 16 sales worth €191k. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 option exercises. In 2026 alone, the filings show 1 purchase and 1 sale.
The median purchase comes to €3,559. Across 11 purchases, this insider has always bought alone, with no colleague buying within 30 days.
On 11 June 2026 came the latest disclosure, an option exercise for €108k in Fennec Pharmaceuticals Inc. The last insider purchase was made public on 11 May 2026, 182 days ago. Most trades are made public on the day they happen. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Chris Anigeron Rallis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ CA$8.70100.0% of flowOptionsTSXSEDI:4734212
- 8,346 shares@ CA$7.055.9% of flowCommon SharesTSXSEDI:4717686
- 14,344 shares@ CA$2.443.5% of flowCommon SharesTSXSEDI:4717685Canonical exit: 9 Aug 2026 (T+90)
- 4,062 shares@ CA$1.232.2% of flowCommon SharesTSXSEDI:4590667Canonical exit: 8 Jan 2026 (T+90)
- 1,775 shares@ CA$9.247.3% of flowCommon SharesTSXSEDI:4590668
- 2,173 shares@ CA$2.302.2% of flowCommon SharesTSXSEDI:4496351Canonical exit: 10 Jul 2025 (T+90)
- 1,409 shares@ CA$4.953.0% of flowCommon SharesTSXSEDI:4496352
- 1,992 shares@ CA$251.0069.0% of flowCommon SharesTSXSEDI:4453540Canonical exit: 15 May 2025 (T+90)
- 1,186 shares@ CA$6.821.1% of flowCommon SharesTSXSEDI:4453542
- 1,406 shares@ CA$4.530.8% of flowCommon SharesTSXSEDI:4387588
- 1,960 shares@ CA$2.550.6% of flowCommon SharesTSXSEDI:4387587Canonical exit: 6 Jan 2025 (T+90)
- 800 shares@ CA$10.451.0% of flowCommon SharesTSXSEDI:4301124
- 1,389 shares@ CA$3.600.6% of flowCommon SharesTSXSEDI:4301121Canonical exit: 14 Jul 2024 (T+90)
- 4,329 shares@ CA$2.311.3% of flowCommon SharesTSXSEDI:4289822Canonical exit: 24 Jun 2024 (T+90)
- 2,114 shares@ CA$10.972.9% of flowCommon SharesTSXSEDI:4289823
- 3,144 shares@ CA$1.592.8% of flowCommon SharesTSXSEDI:4232373Canonical exit: 25 Mar 2024 (T+90)
- 1,390 shares@ CA$10.908.5% of flowCommon SharesTSXSEDI:4232376
- 269 shares@ CA$8.250.3% of flowCommon SharesTSXSEDI:4213869
- 673 shares@ CA$7.850.6% of flowCommon SharesTSXSEDI:4172749
- 6,796 shares@ CA$8.176.2% of flowCommon SharesTSXSEDI:4161641
- 16,666 shares@ CA$0.721.3% of flowCommon SharesTSXSEDI:4161639Canonical exit: 22 Oct 2023 (T+90)
- 5,208 shares@ CA$0.960.6% of flowCommon SharesTSXSEDI:4155167
- 2,207 shares@ CA$8.472.3% of flowCommon SharesTSXSEDI:4155172
- 1,700 shares@ CA$2.940.6% of flowCommon SharesTSXSEDI:4120824
- 916 shares@ CA$8.340.9% of flowCommon SharesTSXSEDI:4120826
25 of 36 declarations
